… For each patient i, let a(i) denote the average dissimilarity to all other patients within the
same subtype and b(i) denote the lowest average dissimilarity to all other patients in different …

… (b) Clinical patient parameters for showing significant association of the radiomic expression
patterns with primary tumour stage (T-stage; P<1 × 10 −20 , χ 2 test), overall stage (P=3.4 × …

… B ) Analysis of patients with HG2 tumors by gene expression grade (GG). The 217 patients
with HG2 tumors were separated into low- and high-risk subsets by GG as GG1 ( green ) and …

… for ischemia time to ensure high-quality PTM analysis of proteins (Figure 1B). Our patient …
were alive at the time of the data freeze for the analysis reported in this study (Figure 1B). …

The particularly interdisciplinary nature of human microbiome research makes the organization
and reporting of results spanning epidemiology, biology, bioinformatics, translational …

… risk alone (B) for TDM. The HRs are shown together with the 95% confidence interval. …
Desmedt, B. Haibe-Kains, and C. Sotiriou was supported by a national grant from the Fonds …

… (b) Dot histograms showing dependence of proliferation score on the subtypes. The median
and quartiles for each group are shown by the box plot. ER - /ERBB2 - and HER2 + tumors …

… Despite tracking a single biologic pathway, these were highly comparable to the previously
described luminal A and B classification and significantly correlated to the risk groups …

Due to advances in the acquisition and analysis of medical imaging, it is currently possible
to quantify the tumor phenotype. The emerging field of Radiomics addresses this issue by …

… This concurs with our findings that (a) proliferation seems to be the main contributor of these
signatures and (b) the ER+/HER2− subgroup is the only molecular subgroup that displays a …